A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn

This study has been completed.

Study NCT00237367 Information provided by PriCara, Unit of Ortho-McNeil, Inc.

First Received: October 7, 2005 Last Updated: April 26, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	April 2005
Estimated Primary Completion Date:	No date given

No publications provided by PriCara, Unit of Ortho-McNeil, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Miner P, Delemos B, Xiang J, Lococo J, Ieni J. Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-h intragastric acidity and oesophageal acid exposure: a randomized study in gastro-oesophageal reflux disease patients with a history of nocturnal heartburn. Aliment Pharmacol Ther. 2010 May;31(9):991-1000. Epub 2010 Feb 2.